683 Capital Management LLC Increased Redhill Biopharma LTD (RDHL) Stake by $3.03 Million; Shares Declined

RedHill Biopharma Ltd. (NASDAQ:RDHL) Corporate Logo

The stake In Redhill Biopharma Ltd (RDHL) was upped held by 683 Capital Management Llc. According to 2018Q2 SEC form the reduction is 22.76%. 378,751 shares were bought by 683 Capital Management Llc as the company’s stock declined 4.11% while stock markets rallied. The major pharmaceuticals company at the end of 2018Q2 was priced at $17.42M. It’s up from 1.66M at the end of the previous reported quarter. Now it had 2.04 million shares held by the hedge fund . $208.38 million is Redhill Biopharma Ltd’s MC. The stock decreased 4.25% or $0.38 during the last trading session, reaching $8.56.RedHill Biopharma Ltd. has volume of 81,337 shares. Since November 10, 2017 RDHL has declined 11.40% and is downtrending. RDHL underperformed by 27.02% the S&P 500.

According to a filing the 683 Capital Management Llc’s stake in Etsy Inc was reduced by 310,000 shares to 175,000 shares valued at $7.38M in 2018Q2. It manages about $566.08M and $1.48B US Long portfolio. 683 Capital Management Llc has cut its stake in Xenia Hotels & Resorts Inc and also reduced its holding in Pg&E Corp (NYSE:PCG) by 250,000 shares in the quarter, for a total of 591,910 shares.

For more RedHill Biopharma Ltd. (NASDAQ:RDHL) news brought out briefly go to: Seekingalpha.com, Seekingalpha.com, Nasdaq.com, Nasdaq.com or Nasdaq.com. The titles are as follows: “RedHill And Talicia: I Say Yes” brought out on November 09, 2018, “Key events next week – healthcare” on October 12, 2018, “RedHill Biopharma to Host Third Quarter 2018 Financial Results Conference Call on November 13, 2018” with a publish date: November 06, 2018, “RedHill Biopharma to Host Analyst and Investor Webcast on TALICIA® for H. pylori infection on October 30, 2018” and the last “Analysis: Positioning to Benefit within ScanSource, EMCORE, PRA Group, Aqua Metals, Compass Minerals …” with publication date: October 16, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.